Steve holds the position of Regulatory Manager at Atlantia Clinical Trials and is also Director at P2F Ventures Limited. In over 20 years in the pharmaceutical industry, he developed his career in clinical research and global project management, whilst working on some unconventional drug products originating from natural ‘bio-extracted’ sources e.g. the Alzheimer’s Disease treatment, galantamine hydrobromide, discovered in the snowdrop/daffodil bulb. In 2008 Steve transferred his development skills to the functional food sector, joining Provexis plc, as Chief Operating Officer. Under his guidance Provexis became the first company to gain a proprietary (Article 13.5) health claim, from EFSA under EC Regulation 1924/2006. That blood circulation claim, for the proprietary tomato extract (Fruitflow™, trade mark of Provexis plc), remains one of very few to be positively reviewed by EFSA.
